tiprankstipranks
Bukwang Pharmaceutical Co., Ltd. (KR:003000)
:003000
South Korea Market
003000
Bukwang Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Bukwang Pharmaceutical Co., Ltd. (003000) Financial Statements

― Followers

Bukwang Pharmaceutical Co., Ltd. Financial Overview

Bukwang Pharmaceutical Co., Ltd.'s market cap is currently ₩403.54B. The company's EPS TTM is ₩60.36; its P/E ratio is 65.77; and it has a dividend yield of 3.15%. Bukwang Pharmaceutical Co., Ltd. is scheduled to report earnings on July 21, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 200.71B₩ 160.09B₩ 125.93B₩ 190.91B₩ 182.49B
Gross Profit₩ 95.72B₩ 74.34B₩ 50.05B₩ 79.43B₩ 75.76B
Operating Income₩ 14.16B₩ 1.62B₩ -37.50B₩ -230.64M₩ 5.62B
EBITDA₩ 19.65B₩ 7.63B₩ -31.47B₩ 4.89B₩ 11.40B
Net Income₩ 12.57B₩ -2.64B₩ -31.33B₩ -2.47B₩ -916.62M
Balance Sheet
Cash & Short-Term Investments₩ 216.21B₩ 130.09B₩ 151.23B₩ 85.52B₩ 84.28B
Total Assets₩ 502.17B₩ 373.18B₩ 429.02B₩ 400.93B₩ 397.42B
Total Debt₩ 80.34B₩ 79.42B₩ 79.39B₩ 930.79M₩ 1.56B
Net Debt₩ 41.13B₩ -10.67B₩ -71.84B₩ -84.59B₩ -81.22B
Total Liabilities₩ 161.24B₩ 129.03B₩ 194.75B₩ 129.08B₩ 117.36B
Stockholders' Equity₩ 341.46B₩ 243.68B₩ 226.31B₩ 263.22B₩ 269.61B
Cash Flow
Free Cash Flow₩ 11.15B₩ 31.75B₩ -13.32B₩ 11.47B₩ 25.74B
Operating Cash Flow₩ 18.48B₩ 34.36B₩ -10.50B₩ 16.46B₩ 26.52B
Investing Cash Flow₩ -95.68B₩ -27.73B₩ -2.32B₩ -3.15B₩ 4.75B
Financing Cash Flow₩ 82.76B₩ -67.65B₩ 76.84B₩ -10.40B₩ -27.48B
Currency in KRW

Bukwang Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Bukwang Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Bukwang Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Bukwang Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >